Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04057105 · ClinicalTrials.gov registry record · NA

Targeted Noninvasive Brain Stimulation (T-NIBS) to Improve Hand Motor Functions in Acquired Brain Injury

A NA study, sponsored by Kessler Foundation.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT04057105 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04057105, a NA study, has completed, sponsored by Kessler Foundation.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

Acquired Brain Injury (TBI) is a serious medical and health problem in the US. Individuals with an acquired brain injury due to stroke and Traumatic Brain Injury (TBI) commonly suffer from upper extremity physical impairments that persist even after years of injury; these deficits are attributed to the damage to brain structure and changes in structural and functional connectivity. Although the conventional rehabilitation approaches are helpful in assisting motor recovery often there is a complaint of fatigue due to the repetitive tasks and also, nearly half of the ABI survivors do not regain their ability to use their arms for daily activities. To address this issue, Dr. Shenoy's proposed study will investigate the combined use of individually targeted non-invasive brain stimulation and music-assisted video game-based hand exercises to achieve functional recovery. Further, the project will also investigate how the intervention modulates brain activity (recorded using EEG) in terms of brain connectivity before- and after the -intervention. In the end, this study will allow us to understand the cortical dynamics of ABI rehabilitation upon brain stimulation. Extending further, this could pave the way to advance the knowledge of behavioral and neural aspects of motor control in patients with different types of neuromuscular disorders.

Interventions

  • DEVICE Active High-definition Transcranial Direct Current Stimulation (HD-tDCS)
  • DEVICE MusicGlove

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2020-10-01
Est. Completion 2024-12-30
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT04057105

The ClinicalTrials.gov registry entry for NCT04057105 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Active High-definition Transcranial Direct Current Stimulation (HD-tDCS) is the first listed.

NCT04057105 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04057105 about?

NCT04057105 is a clinical study titled "Targeted Noninvasive Brain Stimulation (T-NIBS) to Improve Hand Motor Functions in Acquired Brain Injury". Acquired Brain Injury (TBI) is a serious medical and health problem in the US. Individuals with an acquired brain injury due to stroke and Traumatic Brain Injury (TBI) commonly suffer from upper extremity physical impairments that persist even after years of injury; these deficits are attributed to ...

What is the current status of trial NCT04057105?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-10-01. Estimated completion is 2024-12-30.

What interventions are being tested in trial NCT04057105?

The interventions under investigation include: Active High-definition Transcranial Direct Current Stimulation (HD-tDCS) (DEVICE), MusicGlove (DEVICE).

Who is sponsoring clinical trial NCT04057105?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.